Studies for pancreas diseases, Acute and Chronic Pancreatitis.

Current studies:

  • MAP-1 Markers in Acute Pancreatitis.

Current trials:

Randomised treatment of Acute Pancreatitis with Infliximab: double-blind multi-centre trial.